Scientists edge closer to develop a vaccine against the SARS-CoV-2 corona virus and Indian pharmaceutical companies are in front and centre of the race to supply the world with an effective product. However India’s experience as a vaccine manufacturer, its companies have to struggle to produce enough doses sufficiently fast to...
Full ArticleCoronavirus Vaccines: R&D Landscape – Analysis
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Belief In Conspiracy Theories Is Barrier To Controlling Spread Of COVID-19
Eurasia Review
Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to..